As of 1:37pm ET
| -0.12 / -1.51%|
The 4 analysts offering 12-month price forecasts for Neogenomics Inc have a median target of 9.50, with a high estimate of 10.00 and a low estimate of 9.00. The median estimate represents a +21.02% increase from the last price of 7.85.
The current consensus among 5 polled investment analysts is to Buy stock in Neogenomics Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.